FDA: Patients collecting nasal samples at care facilities need clear instructions
![FDA-guidance](/sites/default/files/styles/900x400/public/2018-07/FDA-guidance.jpg?itok=I8jaZmAO)
The Food and Drug Administration yesterday recommended that health care providers provide written or video step-by-step instructions, in addition to verbal instructions, to patients who are self-collecting anterior nares (nasal) samples for COVID-19 testing in a health care setting.
Without clear instructions, patients “may not collect an adequate sample for testing, which may decrease the sensitivity of the test,” the agency said.
Examples of written instructions are available from the Centers for Disease Control and Prevention and Audere, a nonprofit that has granted a general right of reference to use their instructions at a testing site, FDA said.
Related News Articles
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…